340 related articles for article (PubMed ID: 28671058)
1. Dual Roles of Pin1 in Cancer Development and Progression.
Han HJ; Choi BY; Surh YJ
Curr Pharm Des; 2017 Nov; 23(29):4422-4425. PubMed ID: 28671058
[TBL] [Abstract][Full Text] [Related]
2. Role of phosphorylation in determining the backbone dynamics of the serine/threonine-proline motif and Pin1 substrate recognition.
Schutkowski M; Bernhardt A; Zhou XZ; Shen M; Reimer U; Rahfeld JU; Lu KP; Fischer G
Biochemistry; 1998 Apr; 37(16):5566-75. PubMed ID: 9548941
[TBL] [Abstract][Full Text] [Related]
3. The role of Pin1 in the development and treatment of cancer.
Min SH; Zhou XZ; Lu KP
Arch Pharm Res; 2016 Dec; 39(12):1609-1620. PubMed ID: 27572155
[TBL] [Abstract][Full Text] [Related]
4. Recent advances of Pin1 inhibitors as potential anticancer agents.
Bai Y; Yuan Z; Yuan S; He Z
Bioorg Chem; 2024 Mar; 144():107171. PubMed ID: 38325131
[TBL] [Abstract][Full Text] [Related]
5. An irreversible inhibitor of peptidyl-prolyl cis/trans isomerase Pin1 and evaluation of cytotoxicity.
Ieda N; Itoh K; Inoue Y; Izumiya Y; Kawaguchi M; Miyata N; Nakagawa H
Bioorg Med Chem Lett; 2019 Feb; 29(3):353-356. PubMed ID: 30585173
[TBL] [Abstract][Full Text] [Related]
6. Regulation of eukaryotic protein kinases by Pin1, a peptidyl-prolyl isomerase.
Chen XR; Igumenova TI
Adv Biol Regul; 2023 Jan; 87():100938. PubMed ID: 36496344
[TBL] [Abstract][Full Text] [Related]
7. The Peptidyl-Prolyl
Anto NP; Muraleedharan A; Nath PR; Sun Z; Keasar C; Livneh E; Braiman A; Altman A; Kong KF; Isakov N
Front Immunol; 2023; 14():1126464. PubMed ID: 36969236
[TBL] [Abstract][Full Text] [Related]
8. Rhein exhibits antitumorigenic effects by interfering with the interaction between prolyl isomerase Pin1 and c-Jun.
Cho JH; Chae JI; Shim JH
Oncol Rep; 2017 Mar; 37(3):1865-1872. PubMed ID: 28184937
[TBL] [Abstract][Full Text] [Related]
9. Phosphorylation-specific prolyl isomerase Pin1 as a new diagnostic and therapeutic target for cancer.
Finn G; Lu KP
Curr Cancer Drug Targets; 2008 May; 8(3):223-9. PubMed ID: 18473735
[TBL] [Abstract][Full Text] [Related]
10. Pin1-dependent prolyl isomerization regulates dephosphorylation of Cdc25C and tau proteins.
Zhou XZ; Kops O; Werner A; Lu PJ; Shen M; Stoller G; Küllertz G; Stark M; Fischer G; Lu KP
Mol Cell; 2000 Oct; 6(4):873-83. PubMed ID: 11090625
[TBL] [Abstract][Full Text] [Related]
11. Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 directly binds and stabilizes Nrf2 in breast cancer.
Saeidi S; Kim SJ; Guillen-Quispe YN; Jagadeesh ASV; Han HJ; Kim SH; Zhong X; Piao JY; Kim SJ; Jeong J; Shin YJ; Cha YJ; Lee HB; Han W; Min SH; Tian W; Kitamura H; Surh YJ
FASEB J; 2022 Jan; 36(1):e22068. PubMed ID: 34918396
[TBL] [Abstract][Full Text] [Related]
12. The Multiple Roles of Peptidyl Prolyl Isomerases in Brain Cancer.
Stifani S
Biomolecules; 2018 Oct; 8(4):. PubMed ID: 30314361
[TBL] [Abstract][Full Text] [Related]
13. Phosphorylation-dependent prolyl isomerization: a novel signaling regulatory mechanism.
Zhou XZ; Lu PJ; Wulf G; Lu KP
Cell Mol Life Sci; 1999 Nov; 56(9-10):788-806. PubMed ID: 11212339
[TBL] [Abstract][Full Text] [Related]
14. Prolyl isomerase Pin1 in metabolic reprogramming of cancer cells.
Nakatsu Y; Yamamotoya T; Ueda K; Ono H; Inoue MK; Matsunaga Y; Kushiyama A; Sakoda H; Fujishiro M; Matsubara A; Asano T
Cancer Lett; 2020 Feb; 470():106-114. PubMed ID: 31678165
[TBL] [Abstract][Full Text] [Related]
15. [Unexpected roles of the peptidyl-prolyl cis/trans isomerase Pin1].
Lavoie SB; Albert AL; Vincent M
Med Sci (Paris); 2003 Dec; 19(12):1251-8. PubMed ID: 14691750
[TBL] [Abstract][Full Text] [Related]
16. Peptidyl-prolyl cis/trans isomerase NIMA-interacting 1 as a molecular target in breast cancer: a therapeutic perspective of gynecological cancer.
Kim G; Bhattarai PY; Choi HS
Arch Pharm Res; 2019 Feb; 42(2):128-139. PubMed ID: 30684192
[TBL] [Abstract][Full Text] [Related]
17. Oxygen-independent stabilization of HIF-2α in breast cancer through direct interaction with peptidyl-prolyl cis-trans isomerase NIMA-interacting 1.
Guillen-Quispe YN; Kim SJ; Saeidi S; Zhou T; Zheng J; Kim SH; Fang X; Chelakkot C; Rios-Castillo ME; Shin YK; Surh YJ
Free Radic Biol Med; 2023 Oct; 207():296-307. PubMed ID: 37473874
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and Pin1 inhibitory activity of thiazole derivatives.
Zhao H; Cui G; Jin J; Chen X; Xu B
Bioorg Med Chem; 2016 Nov; 24(22):5911-5920. PubMed ID: 27692510
[TBL] [Abstract][Full Text] [Related]
19. Prolyl isomerase Pin1: a catalyst for oncogenesis and a potential therapeutic target in cancer.
Ryo A; Liou YC; Lu KP; Wulf G
J Cell Sci; 2003 Mar; 116(Pt 5):773-83. PubMed ID: 12571275
[TBL] [Abstract][Full Text] [Related]
20. Phosphorylation-specific prolyl isomerization: is there an underlying theme?
Wulf G; Finn G; Suizu F; Lu KP
Nat Cell Biol; 2005 May; 7(5):435-41. PubMed ID: 15867923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
